Annals of Oncology

Obituary:

Francesco Cognetti

Professor Federico Calabresi
Ann Oncol 6: 95.
[PDF] [Request Permissions]

In this issue:

In this issue
Ann Oncol 6: 96.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 6: 96.
[PDF] [Request Permissions]

News:

Bickering between the NCI and NSABP
Ann Oncol 6: 97.
[PDF] [Request Permissions]

Oregon approves assisted suicide measures
Ann Oncol 6: 97.
[PDF] [Request Permissions]

Survey on euthanasia in Britain
Ann Oncol 6: 97-98.
[PDF] [Request Permissions]

Krakoff has bad luck in Scotland
Ann Oncol 6: 98-99.
[PDF] [Request Permissions]

French minister: "We badly need a cancer plan..."
Ann Oncol 6: 99.
[PDF] [Request Permissions]

...and funding for cancer research must be transparent
Ann Oncol 6: 99.
[PDF] [Request Permissions]

ESMO Lisbon: Success cum "cliff hanger"
Ann Oncol 6: 99-100.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 6: 100-101.
[PDF] [Request Permissions]

Book reviews:

F. Cavalli

Book review
Ann Oncol 6: 101.
[PDF] [Request Permissions]

Walter Weber

Book review
Ann Oncol 6: 108.
[PDF] [Request Permissions]

Jürg Bernhard

Book review
Ann Oncol 6: 112.
[PDF] [Request Permissions]

M. Ghielmini

Book review
Ann Oncol 6: 189.
[PDF] [Request Permissions]

Editorials:

J. Verweij and J. H. M. Schellens

Topoisomerase I inhibition: A new target or new missiles?
Ann Oncol 6: 102-104.
[PDF] [Request Permissions]

Jens Benn Sørensen

Current position of vinorelbine in cancer chemotherapy
Ann Oncol 6: 105-107.
[PDF] [Request Permissions]

Special articles:

H. Stein and (founding member of the International Lymphoma Study Group)

Critique of the critique: Response to the editorial entitled ‘Classification of Lymphoid Neoplasms’ by Dr. Saul Rosenberg which accompanied the publication of the ‘Revised European-American Lymphoma Classification Proposal’ in the September 1994 issue of Blood
Ann Oncol 6: 109-111.
[PDF] [Request Permissions]

Review:

C. N. Sternberg

The treatment of advanced bladder cancer
Ann Oncol 6: 113-126.
[PDF] [Request Permissions]

Arena:

R. R. Love

Tamoxifen chemoprevention: Public health goals, toxicities for all and benefits to a few
Ann Oncol 6: 127-128.
[PDF] [Request Permissions]

Original articles:

D. J. Th. Wagener, H. E. R. Verdonk, L. Y. Dirix, G. Catimel, P. Siegenthaler, M. Buitenhuis, A. Mathieu-Boué, and J. Verweij

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study
Ann Oncol 6: 129-132.
[Abstract] [PDF] [Request Permissions]

G. Catimel, G. G. Chabot, J. P. Guastalla, A. Dumortier, C. Cote, C. Engel, A. Gouyette, A. Mathieu-Boué, M. Mahjoubi, and M. Clavel

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors
Ann Oncol 6: 133-140.
[Abstract] [PDF] [Request Permissions]

G. G. Chabot, D. Abigerges, G. Catimel, S. Culine, M. de Forni, J.-M. Extra, M. Mahjoubi, P. Hérait, J.-P. Armand, R. Bugat, M. Clavel, and M. E. Marty

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials^*
Ann Oncol 6: 141-151.
[Abstract] [PDF] [Request Permissions]

E. Jäger, H. Bernhard, O. Klein, B. Wächter, F. Theiss, W. Dippold, K.-H. Meyer zum Büschenfelde, and A. Knuth

Combination 5-fluorouracil (FU), folinic acid (FA), and -interferon 2B in advanced gastric cancer: Results of a phase II trial
Ann Oncol 6: 153-156.
[Abstract] [PDF] [Request Permissions]

R. A. Joss, M. Bacchi, C. Hürny, J. Bernhard, T. Cerny, G. Martinelli, S. Leyvraz, H. J. Senn, R. Stahel, P. Siegenthaler, C. Ludwig, P. Alberto, and for the Swiss Group for Clinical Cancer Research (SAKK)

Early versus late alternating chemotherapy in small-cell lung cancer
Ann Oncol 6: 157-166.
[Abstract] [PDF] [Request Permissions]

The International ChlVPP Treatment Group

ChlVPP therapy for Hodgkin's disease: Experience of 960 patients
Ann Oncol 6: 167-172.
[Abstract] [PDF] [Request Permissions]

L. Salvagno, M. Sorarù, G. Sotti, S. Aversa, V. Chiarion Sileni, R. Mazzarotto, G. Scarzello, A. Bianco, G. L. Pappagallo, and M. V. Fiorentino

Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease
Ann Oncol 6: 173-179.
[Abstract] [PDF] [Request Permissions]

Clinical case:

P. D. Simmonds, G. M. Mead, and J. M. A. Whitehouse

A complicated case of metastatic teratoma: Growing teratoma syndrome and cerebral metastasis
Ann Oncol 6: 181-185.
[PDF] [Request Permissions]

Short report:

A. Fabi, R. Tonachella, A. Savarese, S. Cirulli, S. Tomao, E. Conte, and F. Cognetti

A phase II trial of vinorelbine and thiotepa in metastatic breast cancer
Ann Oncol 6: 187-189.
[Abstract] [PDF] [Request Permissions]

A. S. T. Planting, M. E. L. van der Burg, M. de Boer-Dennert, G. Stoter, and J. Verweij

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors
Ann Oncol 6: 190-192.
[Abstract] [PDF] [Request Permissions]

S. Toma, R. Palumbo, A. Comandone, C. Oliva, M. Vincenti, C. Bumma, and R. Rosso

Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: A phase I study
Ann Oncol 6: 193-196.
[Abstract] [PDF] [Request Permissions]

Letters:

P. Fuchsberger and J. Lakota

High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas – first experience in the Slovak Republic
Ann Oncol 6: 197-198.
[PDF] [Request Permissions]

A. M. Gianni

Comment on the letter from Fuchsberger and Lakota
Ann Oncol 6: 198.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements:

Classfied advertisements from ESMO members and meeting announcements
Ann Oncol 6: 199.
[PDF] [Request Permissions]

ESMO membership application forms:

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Ann Oncol 6: 200.
[PDF] [Request Permissions]

ESMO congress 2000 and 2002:

Application for the organization of the ESMO Congress 2000 and 2002
Ann Oncol 6: 201.
[PDF] [Request Permissions]

KLUWER ACADEMIC PUBLISHERS GROUP:

KLUWER ACADEMIC PUBLISHERS
Ann Oncol 6: 202.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.